N. Saunders, C. Ek, M. Habgood, and K. Dziegielewska, Barriers in the brain: a renaissance? Trends Neurosci, pp.279-86, 2008.

B. Zlokovic, The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders, Neuron, vol.57, issue.2, pp.178-201, 2008.
DOI : 10.1016/j.neuron.2008.01.003

D. Brown and P. Sawchenko, Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis, The Journal of Comparative Neurology, vol.420, issue.2, pp.236-60, 2007.
DOI : 10.1002/cne.21307

A. Reboldi, C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli et al., C-C chemokine receptor 6???regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE, Nature Immunology, vol.181, issue.5, pp.514-537, 2009.
DOI : 10.1002/glia.1101

B. Engelhardt, K. Wolburg?buchholz, and H. Wolburg, Involvement of the choroid plexus in central nervous system inflammation, Microscopy Research and Technique, vol.21, issue.1, pp.112-141, 2001.
DOI : 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5

S. Ousman and P. Kubes, Immune surveillance in the central nervous system, Nature Neuroscience, vol.14, issue.8, 2012.
DOI : 10.1084/jem.20070885

N. Abbott, L. Ronnback, and E. Hansson, Astrocyte???endothelial interactions at the blood???brain barrier, Nature Reviews Neuroscience, vol.15, issue.1, pp.41-53, 2006.
DOI : 10.1046/j.1469-7580.2002.00065.x

L. Rubin and J. Staddon, THE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER, Annual Review of Neuroscience, vol.22, issue.1, pp.11-28, 1999.
DOI : 10.1146/annurev.neuro.22.1.11

S. Aijaz, M. Balda, and K. Matter, Tight Junctions, Int Rev Cytol, vol.248, issue.06, pp.261-98, 2006.
DOI : 10.1007/3-540-29623-9_3460

B. Obermeier, R. Daneman, and R. Ransohoff, Development, maintenance and disruption of the blood-brain barrier, Nature Medicine, vol.12, issue.12, pp.1584-96, 2013.
DOI : 10.1253/circj.CJ-11-0121

G. Ricci, L. Volpi, L. Pasquali, L. Petrozzi, and G. Siciliano, Astrocyte???neuron interactions in neurological disorders, Journal of Biological Physics, vol.5, issue.12, pp.317-353, 2009.
DOI : 10.1007/s10867-009-9157-9

A. Shih, H. Fernandes, F. Choi, M. Kozoriz, Y. Liu et al., Policing the Police: Astrocytes Modulate Microglial Activation, Journal of Neuroscience, vol.26, issue.15, pp.3887-3895, 2006.
DOI : 10.1523/JNEUROSCI.0936-06.2006

A. Armulik, G. Genove, M. M. Nisancioglu, M. Wallgard, E. Niau?-det et al., Pericytes regulate the blood???brain barrier, Nature, vol.57, issue.7323, pp.557-61, 2010.
DOI : 10.1038/nature09522

N. Abbott, Astrocyte-endothelial interactions and blood-brain barrier permeability*, Journal of Anatomy, vol.200, issue.6, pp.629-667, 2002.
DOI : 10.1046/j.1469-7580.2002.00064.x

A. Sebastiao and J. Ribeiro, Adenosine Receptors and the Central Nervous System, Handb Exp Pharmacol, vol.193, pp.471-534, 2009.
DOI : 10.1007/978-3-540-89615-9_16

T. Stone, S. Ceruti, and M. Abbracchio, Adenosine Receptors and Neurological Disease: Neuroprotection and Neurodegeneration, Handb Exp Pharmacol, vol.193, pp.535-87, 2009.
DOI : 10.1007/978-3-540-89615-9_17

G. Yegutkin, Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1783, issue.5, pp.673-94, 2008.
DOI : 10.1016/j.bbamcr.2008.01.024

H. Zimmermann, 5???-Nucleotidase: molecular structure and functional aspects, Biochemical Journal, vol.285, issue.2, pp.345-65, 1992.
DOI : 10.1042/bj2850345

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1132794/pdf

J. Barankiewicz, A. Danks, E. Abushanab, L. Makings, T. Wiemann et al., Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors, J Pharmacol Exp Ther, vol.283, issue.3, pp.1230-1238, 1997.

H. Lloyd and B. Fredholm, Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices, Neurochemistry International, vol.26, issue.4, pp.387-95, 1995.
DOI : 10.1016/0197-0186(94)00144-J

K. Jacobson and Z. Gao, Adenosine receptors as therapeutic targets, Nature Reviews Drug Discovery, vol.357, issue.3, pp.247-64, 2006.
DOI : 10.1016/S0960-894X(02)00609-1

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463109

C. Wei, W. Li, and J. Chen, Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1808, issue.5, pp.1358-79, 2011.
DOI : 10.1016/j.bbamem.2010.12.018

G. Hasko, J. Linden, B. Cronstein, and P. Pacher, Adenosine receptors: thera? peutic aspects for inflammatory and immune diseases, Nat Rev Drug Discovery, vol.7, issue.9, pp.759-70, 2008.
DOI : 10.1201/9781420005776

B. Fredholm, A. Ijzerman, K. Jacobson, K. Klotz, and J. Linden, Interna? tional Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, Pharmacol Rev, vol.53, issue.4, pp.527-52, 2001.

B. Fredholm, A. Ijzerman, K. Jacobson, J. Linden, and C. Muller, International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update, Pharmacological Reviews, vol.63, issue.1, pp.1-34, 2011.
DOI : 10.1124/pr.110.003285

A. Carman, J. Mills, A. Krenz, D. Kim, and M. Bynoe, Adenosine Receptor Signaling Modulates Permeability of the Blood-Brain Barrier, Journal of Neuroscience, vol.31, issue.37, pp.13272-80, 2011.
DOI : 10.1523/JNEUROSCI.3337-11.2011

H. Eltzschig, M. Sitkovsky, and S. Robson, Purinergic Signaling during Inflammation, New England Journal of Medicine, vol.367, issue.24, pp.2322-2355, 2012.
DOI : 10.1056/NEJMra1205750

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675791

A. Dixon, A. Gubitz, D. Sirinathsinghji, P. Richardson, and T. Freeman, Tissue distribution of adenosine receptor mRNAs in the rat, British Journal of Pharmacology, vol.89, issue.6, pp.1461-1469, 1996.
DOI : 10.1111/j.1476-5381.1996.tb15561.x

L. Mahan, L. Mcvittie, E. Smyk?randall, H. Nakata, F. Monsma et al., Cloning and expression of an A1 adenosine receptor from rat brain, Mol Pharmacol, vol.40, issue.1, pp.1-7, 1991.

B. Fredholm, G. Arslan, L. Halldner, B. Kull, G. Schulte et al., Structure and function of adenosine receptors and their genes, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.362, issue.4-5, pp.4-5364, 2000.
DOI : 10.1007/s002100000313

J. Johnston, C. Silva, G. Gonzalez, J. Holden, K. Warren et al., Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis, Annals of Neurology, vol.56, issue.5, pp.650-658, 2001.
DOI : 10.1002/ana.1007

J. Mills, D. Kim, A. Krenz, J. Chen, and M. Bynoe, A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis, The Journal of Immunology, vol.188, issue.11, pp.5713-5735, 2012.
DOI : 10.4049/jimmunol.1200545

D. Rosin, A. Robeva, R. Woodard, P. Guyenet, and J. Linden, Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system, The Journal of Comparative Neurology, vol.50, issue.2, pp.163-86, 1998.
DOI : 10.1002/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D

S. Schiffmann, F. Libert, G. Vassart, and J. Vanderhaeghen, Distribution of adenosine A2 receptor mRNA in the human brain, Neuroscience Letters, vol.130, issue.2, pp.177-81, 1991.
DOI : 10.1016/0304-3940(91)90391-6

P. Svenningsson, H. Hall, G. Sedvall, and B. Fredholm, Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study, SICI)1098?23964<322:AID?SYN6>3.0.CO;2?E, pp.322-357, 1997.
DOI : 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E

X. Li, T. Nomura, H. Aihara, and T. Nishizaki, Adenosine enhances glial glutamate efflux via A2a adenosine receptors, Life Sciences, vol.68, issue.12, pp.1343-50, 2001.
DOI : 10.1016/S0024-3205(00)01036-5

M. Matos, E. Augusto, P. Agostinho, R. Cunha, and J. Chen, Antagonistic Interaction between Adenosine A2A Receptors and Na+/K+-ATPase-??2 Controlling Glutamate Uptake in Astrocytes, Journal of Neuroscience, vol.33, issue.47, pp.18492-502, 2013.
DOI : 10.1523/JNEUROSCI.1828-13.2013

M. Matos, E. Augusto, A. Santos?rodrigues, M. Schwarzschild, J. Chen et al., Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes, Glia, vol.63, issue.5, pp.702-718, 2012.
DOI : 10.1002/glia.22290

B. Fredholm and P. Svenningsson, Adenosine-dopamine interactions: Development of a concept and some comments on therapeutic possibilities, Neurology, vol.61, issue.Issue 11, Supplement 6, pp.5-9, 2003.
DOI : 10.1212/01.WNL.0000095204.89871.FF

S. Colgan, H. Eltzschig, T. Eckle, and L. Thompson, Physiological roles for ecto?5??nucleotidase (CD73) Purinergic Signal, pp.351-60, 2006.

G. Burnstock and J. Boeynaems, Purinergic signalling and immune cells, Purinergic Signalling, vol.308, issue.Suppl 1, pp.529-64, 2014.
DOI : 10.1007/s11302-014-9427-2

J. Mills, L. Thompson, C. Mueller, A. Waickman, S. Jalkanen et al., CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis, Proceedings of the National Academy of Sciences, vol.105, issue.27, pp.9325-9355, 2008.
DOI : 10.1073/pnas.0711175105

P. Koszalka, B. Ozuyaman, Y. Huo, A. Zernecke, U. Flogel et al., Targeted Disruption of cd73/Ecto-5'-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response, Circulation Research, vol.95, issue.8, pp.814-835, 2004.
DOI : 10.1161/01.RES.0000144796.82787.6f

J. Mills, L. Alabanza, B. Weksler, P. Couraud, I. Romero et al., Human brain endothelial cells are responsive to adenosine receptor activation, Purinergic Signalling, vol.138, issue.2, pp.265-73, 2011.
DOI : 10.1007/s11302-011-9222-2

L. Airas, J. Niemela, G. Yegutkin, and S. Jalkanen, Mechanism of Action of IFN-beta in the Treatment of Multiple Sclerosis: A Special Reference to CD73 and Adenosine, Annals of the New York Academy of Sciences, vol.285, issue.2, pp.641-649, 2007.
DOI : 10.1002/eji.1830270137

D. Kim and M. Bynoe, A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability, Molecular Neurobiology, vol.39, issue.Pt 12, pp.10-1007, 2014.
DOI : 10.1517/13543780903052764

S. Narravula, P. Lennon, B. Mueller, and S. Colgan, Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function, The Journal of Immunology, vol.165, issue.9, pp.5262-5270, 2000.
DOI : 10.4049/jimmunol.165.9.5262

G. Hasko, P. Pacher, E. Vizi, and P. Illes, Adenosine receptor signaling in the brain immune system, Trends in Pharmacological Sciences, vol.26, issue.10, pp.511-517, 2005.
DOI : 10.1016/j.tips.2005.08.004

B. Stevens, S. Porta, L. Haak, V. Gallo, and R. Fields, Adenosine, Neuron, vol.36, issue.5, pp.855-68, 2002.
DOI : 10.1016/S0896-6273(02)01067-X

E. Dare, G. Schulte, O. Karovic, C. Hammarberg, and B. Fredholm, Modulation of glial cell functions by adenosine receptors, Physiology & Behavior, vol.92, issue.1-2, pp.15-20, 2007.
DOI : 10.1016/j.physbeh.2007.05.031

R. Ciccarelli, P. Ballerini, G. Sabatino, M. Rathbone, D. Onofrio et al., Involvement of astrocytes in purine-mediated reparative processes in the brain, International Journal of Developmental Neuroscience, vol.19, issue.4, pp.395-414, 2001.
DOI : 10.1016/S0736-5748(00)00084-8

R. Fields and G. Burnstock, Purinergic signalling in neuron???glia interactions, Nature Reviews Neuroscience, vol.15, issue.6, pp.423-459, 1928.
DOI : 10.1038/nrn1928

K. Biber, K. Klotz, M. Berger, P. Gebicke?harter, and D. Van-calker, Adenosine A1 receptor?mediated activation of phospholipase C in cultured astro? cytes depends on the level of receptor expression, J Neurosci Off J Soc Neurosci, vol.17, issue.13, pp.4956-64, 1997.

D. Mahamed, J. Mills, C. Egan, E. Denkers, and M. Bynoe, CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system, Proceedings of the National Academy of Sciences, vol.109, issue.40, pp.16312-16319, 2012.
DOI : 10.1073/pnas.1205589109

E. Bjorklund, B. Styrishave, G. Anskjaer, M. Hansen, and B. Halling?sorensen, Dichlobenil and 2,6?dichlorobenzamide (BAM) in the environ? ment: what are the risks to humans and biota? Sci Total Environ, pp.3732-3741, 2011.

D. 'alimonte, I. Ballerini, P. Nargi, E. Buccella, S. Giuliani et al., Staurosporine-induced apoptosis in astrocytes is prevented by A1 adenosine receptor activation, Neuroscience Letters, vol.418, issue.1, pp.66-71, 2007.
DOI : 10.1016/j.neulet.2007.02.061

M. Wittendorp, H. Boddeke, and K. Biber, Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes, Glia, vol.89, issue.4, pp.410-418, 2004.
DOI : 10.1002/glia.20016

X. Chen, J. Gawryluk, J. Wagener, O. Ghribi, and J. Geiger, Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease, Journal of Neuroinflammation, vol.5, issue.1, pp.12-22, 2008.
DOI : 10.1186/1742-2094-5-12

X. Chen, X. Lan, I. Roche, R. Liu, and J. Geiger, Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum, Journal of Neurochemistry, vol.107, issue.4, pp.1147-57, 2008.
DOI : 10.1111/j.1471-4159.2008.05697.x

B. Wojciak?stothard, S. Potempa, T. Eichholtz, and A. Ridley, Rho and Rac but not Cdc42 regulate endothelial cell permeability, J Cell Sci, vol.114, pp.1343-55, 2001.

B. Dewi, T. Takasaki, and I. Kurane, In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection, Journal of Virological Methods, vol.121, issue.2, pp.171-80, 2004.
DOI : 10.1016/j.jviromet.2004.06.013

T. Jou, E. Schneeberger, and W. Nelson, Structural and Functional Regulation of Tight Junctions by RhoA and Rac1 Small GTPases, The Journal of Cell Biology, vol.5, issue.1, pp.101-116, 1998.
DOI : 10.1083/jcb.139.4.929

G. Schreibelt, G. Kooij, A. Reijerkerk, R. Van-doorn, S. Gringhuis et al., Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling, The FASEB Journal, vol.21, issue.13, pp.3666-76, 2007.
DOI : 10.1096/fj.07-8329com

M. Sohail, A. Hashmi, H. W. Watanabe, A. Zipprich, A. Groszmann et al., Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition, Hepatology, vol.37, issue.Suppl 2, pp.185-94, 2009.
DOI : 10.1002/hep.22589

S. Sheth, R. Brito, D. Mukherjea, L. Rybak, and V. Ramkumar, Adenosine Receptors: Expression, Function and Regulation, International Journal of Molecular Sciences, vol.15, issue.2, pp.2024-52, 2014.
DOI : 10.3390/ijms15022024

J. Linden, CELL BIOLOGY: Purinergic Chemotaxis, Science, vol.314, issue.5806, pp.1689-90, 2006.
DOI : 10.1126/science.1137190

M. Salmi and S. Jalkanen, Cell-surface enzymes in control of leukocyte trafficking, Nature Reviews Immunology, vol.17, issue.10, pp.760-71, 2005.
DOI : 10.1038/nri1705

D. Petrovic?djergovic, M. Hyman, J. Ray, D. Bouis, S. Visovatti et al., Tissue-Resident Ecto-5' Nucleotidase (CD73) Regulates Leukocyte Trafficking in the Ischemic Brain, The Journal of Immunology, vol.188, issue.5, pp.2387-98, 2012.
DOI : 10.4049/jimmunol.1003671

M. Takedachi, D. Qu, Y. Ebisuno, H. Oohara, M. Joachims et al., CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes, The Journal of Immunology, vol.180, issue.9, pp.6288-96, 2008.
DOI : 10.4049/jimmunol.180.9.6288

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709497

L. Thompson, M. Takedachi, Y. Ebisuno, T. Tanaka, M. Miyasaka et al., Regulation of Leukocyte Migration Across Endothelial Barriers by ECTO-5???-Nucleotidase-Generated Adenosine, Nucleosides, Nucleotides and Nucleic Acids, vol.165, issue.6-7, pp.755-6010, 1080.
DOI : 10.1152/ajpcell.00132.2004

S. Tsutsui, J. Schnermann, F. Noorbakhsh, S. Henry, V. Yong et al., A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple Sclerosis, Journal of Neuroscience, vol.24, issue.6, pp.1521-1530, 2004.
DOI : 10.1523/JNEUROSCI.4271-03.2004

G. Chen, Y. Chen, X. Wang, S. Wu, H. Yang et al., Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats, Brain Research, vol.1309, pp.116-141, 2010.
DOI : 10.1016/j.brainres.2009.10.054

M. Schwartz and K. Baruch, The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus, The EMBO Journal, vol.9, issue.Suppl 2, pp.7-22, 2014.
DOI : 10.1002/embj.201386609

T. Imai, K. Hieshima, C. Haskell, M. Baba, M. Nagira et al., Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion, Cell, vol.91, issue.4, pp.521-551, 1997.
DOI : 10.1016/S0092-8674(00)80438-9

J. Mills, L. Alabanza, D. Mahamed, and M. Bynoe, Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experi? mental autoimmune encephalomyelitis, J Neuroinflamm, vol.9, pp.193-203, 2012.

N. Schwarz, J. Pruessmeyer, F. Hess, D. Dreymueller, E. Pantaler et al., Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1, Cellular and Molecular Life Sciences, vol.20, issue.24, pp.4233-4281, 2010.
DOI : 10.1007/s00018-010-0433-4

D. Sunnemark, S. Eltayeb, M. Nilsson, E. Wallstrom, H. Lassmann et al., CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein?induced experimental autoimmune encephalomyelitis: kinetics and cellular origin, Journal of Neuroinflammation, vol.2, issue.1, pp.17-27, 2005.
DOI : 10.1186/1742-2094-2-17

S. Kastenbauer, U. Koedel, M. Wick, B. Kieseier, H. Hartung et al., CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system, Journal of Neuroimmunology, vol.137, issue.1-2, pp.210-217, 2003.
DOI : 10.1016/S0165-5728(03)00085-7

B. Broux, K. Pannemans, X. Zhang, S. Markovic?plese, T. Broekmans et al., CX3CR1 drives cytotoxic CD4+CD28??? T cells into the brain of multiple sclerosis patients, Journal of Autoimmunity, vol.38, issue.1, pp.10-19, 2012.
DOI : 10.1016/j.jaut.2011.11.006

M. Rancan, N. Bye, V. Otto, O. Trentz, T. Kossmann et al., The Chemokine Fractalkine in Patients With Severe Traumatic Brain Injury and a Mouse Model of Closed Head Injury, Journal of Cerebral Blood Flow & Metabolism, vol.115, issue.10, pp.1110-1118, 2004.
DOI : 10.1097/01.WCB.0000133470.91843.72

D. Huang, F. Shi, S. Jung, G. Pien, J. Wang et al., The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system, The FASEB Journal, vol.20, issue.7, pp.896-905, 2006.
DOI : 10.1096/fj.05-5465com

J. Hao, R. Liu, W. Piao, Q. Zhou, T. Vollmer et al., Central nervous system (CNS)???resident natural killer cells suppress Th17 responses and CNS autoimmune pathology, The Journal of Experimental Medicine, vol.6, issue.9, pp.1907-1928, 2010.
DOI : 10.1016/j.immuni.2009.05.001

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931174

S. Hossain, T. Akaike, and E. Chowdhury, Current Approaches for Drug Delivery to Central Nervous System, Current Drug Delivery, vol.7, issue.5, pp.389-97, 2010.
DOI : 10.2174/156720110793566245

M. Rajadhyaksha, T. Boyden, J. Liras, A. El?kattan, and J. Brodfuehrer, Current Advances in Delivery of Biotherapeutics Across the Blood-Brain Barrier, Current Drug Discovery Technologies, vol.8, issue.2, pp.87-101, 2011.
DOI : 10.2174/157016311795563866

W. Pardridge, The blood-brain barrier: Bottleneck in brain drug development, NeuroRX, vol.550, issue.1, pp.3-14, 2005.
DOI : 10.1602/neurorx.2.1.3

E. Neuwelt, E. Frenkel, J. Diehl, K. Maravilla, L. Vu et al., Osmotic blood?brain barrier disruption: a new means of increas? ing chemotherapeutic agent delivery, Trans Am Neurol Assoc, vol.104, pp.256-60, 1979.

E. Neuwelt, H. Specht, J. Howieson, J. Haines, M. Bennett et al., Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning, American Journal of Roentgenology, vol.141, issue.4, pp.829-864, 1983.
DOI : 10.2214/ajr.141.4.829

N. Marchi, L. Angelov, T. Masaryk, V. Fazio, T. Granata et al., Seizure-Promoting Effect of Blood?Brain Barrier Disruption, Epilepsia, vol.17, issue.1, pp.732-774, 2007.
DOI : 10.1002/cncr.21220

C. Borlongan and D. Emerich, Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport, Brain Research Bulletin, vol.60, issue.3, pp.297-306, 2003.
DOI : 10.1016/S0361-9230(03)00043-1

M. Prados, S. Schold, H. Fine, K. Jaeckle, F. Hochberg et al., A randomized, double?blind, placebo?controlled, phase 2 study of RMP?7 in combination with carboplatin administered intrave? nously for the treatment of recurrent malignant glioma, Neuro Oncol, vol.5, issue.2, pp.96-103, 2003.

R. Bartus, P. Elliott, R. Dean, N. Hayward, T. Nagle et al., Controlled Modulation of BBB Permeability Using the Bradykinin Agonist, RMP-7, Experimental Neurology, vol.142, issue.1, pp.14-28, 1996.
DOI : 10.1006/exnr.1996.0175

K. Matsukado, T. Inamura, S. Nakano, M. Fukui, R. Bartus et al., Enhanced Tumor Uptake of Carboplatin and Survival in Glioma-bearing Rats by Intracarotid Infusion of Bradykinin Analog, RMP-7, Neurosurgery, vol.39, issue.1, pp.125-158, 1996.
DOI : 10.1097/00006123-199607000-00025

D. Emerich, P. Snodgrass, R. Dean, M. Agostino, B. Hasler et al., Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters, British Journal of Cancer, vol.80, issue.7, pp.964-70, 1999.
DOI : 10.1038/sj.bjc.6690450

P. Elliott, N. Hayward, R. Dean, D. Blunt, and R. Bartus, Intravenous RMP?7 selectively increases uptake of carboplatin into rat brain tumors, Cancer Res, vol.56, issue.17, pp.3998-4005, 1996.

A. Cook, K. Mieure, R. Owen, A. Pesaturo, and J. Hatton, Intracerebroventricular Administration of Drugs, Pharmacotherapy, vol.145, issue.7, pp.832-877, 2009.
DOI : 10.2165/00003088-200746070-00002

W. Bradley and . Jr, MR-Guided Focused Ultrasound: A Potentially Disruptive Technology, Journal of the American College of Radiology, vol.6, issue.7, pp.510-513, 2009.
DOI : 10.1016/j.jacr.2009.01.004

K. Witt, T. Gillespie, J. Huber, R. Egleton, and T. Davis, Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability, Peptides, vol.22, issue.12, pp.2329-2372, 2001.
DOI : 10.1016/S0196-9781(01)00537-X

A. Granholm, C. Backman, F. Bloom, T. Ebendal, G. Gerhardt et al., NGF and anti?transferrin receptor antibody conjugate: short and long?term effects on survival of cholinergic neurons in intraocular septal transplants, J Pharmacol Exp Therap, vol.268, issue.1, pp.448-59, 1994.

Y. Yu, J. Atwal, Y. Zhang, R. Tong, K. Wildsmith et al., Thera? peutic bispecific antibodies cross the blood?brain barrier in nonhu? man primates, Sci Trans Med, vol.6, issue.261, 2014.

D. Thakker, M. Weatherspoon, J. Harrison, T. Keene, D. Lane et al., Intracerebroventricular amyloid-?? antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice, Proceedings of the National Academy of Sciences, vol.106, issue.11, pp.4501-4507, 2009.
DOI : 10.1073/pnas.0813404106

J. Bicker, G. Alves, F. A. Falcao, and A. , Blood???brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review, European Journal of Pharmaceutics and Biopharmaceutics, vol.87, issue.3, pp.409-441, 2014.
DOI : 10.1016/j.ejpb.2014.03.012